Edition:
United Kingdom

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

22.50USD
18 Oct 2018
Change (% chg)

$0.15 (+0.67%)
Prev Close
$22.35
Open
$22.50
Day's High
$22.70
Day's Low
$22.43
Volume
105,900
Avg. Vol
664,889
52-wk High
$27.32
52-wk Low
$8.68

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.39 -0.655
Mar '18 0.48 -0.214
Dec 0.60 -0.016
Sep 0.69 -0.811
FY 2017 Jun '17 0.64 -0.485
Mar '17 1.32 -0.550
Dec 0.38 -0.234
Sep 0.74 -0.169
FY 2016 Jun '16 0.93 -0.167
Mar '16 0.90 -0.148
Dec 0.67 -0.145
Sep 0.73 -0.163
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 4.27 12.70 0.00 --
Quarter Ending Sep-19 1 22.80 22.80 22.80 --
Year Ending Jun-18 4 5.15 14.40 1.80 --
Year Ending Jun-19 5 35.63 58.30 7.00 35.60
Year Ending Jun-20 6 141.65 195.40 91.20 126.85
Earnings (per share)
Quarter Ending Jun-18 4 -0.22 -0.05 -0.31 --
Quarter Ending Sep-19 2 -0.24 -0.09 -0.39 --
Year Ending Jun-18 3 -1.26 -1.24 -1.29 --
Year Ending Jun-19 6 -1.17 -0.85 -1.56 -0.26
Year Ending Jun-20 6 -0.93 -0.36 -1.50 -0.49
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.83 33.69
P/E High - Last 5 Yrs. -- 288.76 45.21
P/E Low - Last 5 Yrs. -- 90.17 23.79
Beta 1.59 0.93 0.88
Price to Sales (TTM) 472.92 123.60 5.82
Price to Book (MRQ) -- 15.31 4.89
Price to Tangible Book (MRQ) -- 14.52 6.52
Price to Cash Flow (TTM) -- 70.45 22.95
% Owned Institutions 74.12 14.08 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg 0.00 0.24 1.52
Dividend 5 Year Growth Rate -- 2.55 5.39
Payout Ratio(TTM) -- 16.83 43.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -31.15 413.48 8.02
Sales (TTM) vs TTM 1 Yr. Ago -4.39 103.91 5.75
Sales - 5 Yr. Growth Rate -37.62 30.81 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -189.81 24.33 23.65
EPS (TTM) vs TTM 1 Yr. Ago -130.72 -- --
EPS - 5 Yr. Growth Rate -- 37.81 10.95
Capital Spending - 5 Yr. Growth Rate 26.46 38.61 14.90

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.28 1.94 2.25
Current Ratio (MRQ) 1.29 5.34 3.05
LT Debt to Equity (MRQ) -- 34.95 12.73
Total Debt to Equity (MRQ) -- 36.76 17.15
Interest Coverage (TTM) -11.39 -97.17 37.58

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 84.39 40.15 54.90
Gross Margin - 5 Yr. Avg. 85.27 49.21 52.43
EBITD Margin (TTM) -2,530.57 -- --
EBITD - 5 Yr. Avg -950.32 -575.88 11.08
Operating Margin (TTM) -2,560.44 -770.08 4.31
Operating Margin - 5 Yr. Avg. -900.69 -596.20 6.43
Pre-Tax Margin (TTM) -4,957.38 -732.14 5.36
Pre-Tax Margin - 5 Yr. Avg. -1,202.66 -601.79 6.86
Net Profit Margin (TTM) -4,958.05 -733.08 1.64
Net Profit Margin - 5 Yr. Avg. -1,183.71 -604.76 3.11
Effective Tax Rate (TTM) -- 23.64 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.79 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 22,400 22,788,701 810,573,943
Net Income/Employee (TTM) -1,110,625 1,717,126 95,338,757
Receivable Turnover (TTM) 6.17 19.81 5.77
Inventory Turnover (TTM) 1.04 2.38 3.62
Asset Turnover (TTM) 0.03 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -139.64 -1.09 10.92
Return on Assets - 5 Yr. Avg. -85.73 3.20 12.03
Return on Investment (TTM) -367.82 0.58 14.30
Return on Investment - 5 Yr. Avg. -119.48 2.28 15.63
Return on Equity (TTM) -- 1.62 16.03
Return on Equity - 5 Yr. Avg. -4,597.47 3.07 16.90
  1 Year 3 Year 5 Year
Sales % -4.39 -30.08 -37.62
EPS (TTM) % -135.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immunomedics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.19 -4.59 71 59
13 Week 38.48 31.74 99 63
26 Week 99.15 84.01 99 76
52 Week 346.74 278.65 99 47
YTD 217.71 179.01 99 57
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.58%
# of Holders: 276
Total Shares Held: 150,546,332
3 Mo. Net Change: 919,984
# New Positions: 9
# Closed Positions: 1
# Increased Positions: 25
# Reduced Positions: 9
# Net Buyers: 16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.